BMY240426P00046000 Option on Bristol Myers Squibb
| BMY Stock | USD 43.99 0.29 0.66% |
Bristol Myers' option chain provides insight into all available option contracts written on Bristol Myers' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Bristol Myers' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Bristol option contract.
In The Money vs. Out of Money Option Contracts on Bristol Myers
Analyzing Bristol Myers' in-the-money options over time can help investors to take a profitable long position in Bristol Myers regardless of its overall volatility. This is especially true when Bristol Myers' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Bristol Myers' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Bristol Myers' stock while costing only a fraction of its price.
Bristol Myers' latest option contracts expiring on 2024-05-03 are carrying combined implied volatility of 53.19 with a put-to-call open interest ratio of 0.59 over 90 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-05-03. The current put volume is at 611, with calls trading at the volume of 1673. This yields a 0.37 put-to-call volume ratio. The Bristol Myers option chain provides detailed quote and price information for the current Bristol Myers Squibb option contracts. It shows all of Bristol Myers' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-03 Option Contracts
Bristol Myers option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Bristol Myers' lending market. For example, when Bristol Myers' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Bristol Myers, he or she must hedge the risk by shorting Bristol Myers stock over its option's life.
2024-05-03
The chart above shows Bristol Myers' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bristol Myers' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bristol Myers' option, there is no secondary market available for investors to trade.
Bristol Myers Maximum Pain Price across 2024-05-03 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Bristol Myers close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Bristol Myers' stock options are financial instruments that give investors the right to buy or sell shares of Bristol Myers Squibb common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Bristol stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Bristol Myers' stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. Please note that buying 'in-the-money' options on Bristol Myers lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Bristol Myers' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Bristol Myers contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Bristol Stock moves the wrong way.
At this time, Bristol Myers' Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 15 B in 2024. Bristol Myers Squibb In The Money Call Balance
When Bristol Myers' strike price is surpassing the current stock price, the option contract against Bristol Myers Squibb stock is said to be in the money. When it comes to buying Bristol Myers' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Bristol Myers Squibb are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Bristol Current Options Market Mood
Bristol Myers' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bristol Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Bristol Myers' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Bristol Myers' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Bristol Myers' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Bristol contract
Base on the Rule 16, the options market is currently suggesting that Bristol Myers Squibb will have an average daily up or down price movement of about 3.32% per day over the life of the 2024-05-03 option contract. With Bristol Myers trading at USD 43.99, that is roughly USD 1.46. If you think that the market is fully incorporating Bristol Myers' daily price movement you should consider buying Bristol Myers Squibb options at the current volatility level of 53.19%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Bristol |
Purchasing Bristol Myers options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Bristol calls. Remember, the seller must deliver Bristol Myers Squibb stock to the call owner when a call is exercised.
Bristol Myers Option Chain
When Bristol Myers' strike price is surpassing the current stock price, the option contract against Bristol Myers Squibb stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-05-032024-05-102024-05-172024-05-242024-05-312024-06-072024-06-142024-06-212024-07-192024-08-162024-09-202024-10-182024-12-202025-01-172025-05-162025-06-202025-08-152025-11-212026-01-16
Bristol Myers' option chain is a display of a range of information that helps investors for ways to trade options on Bristol. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bristol. It also shows strike prices and maturity days for a Bristol Myers against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-03 CALL at $35.0 | 0.8443 | 0.0219 | 1 | 2024-05-03 | 7.45 - 9.7 | 9.64 | In |
Call | 2024-05-03 CALL at $36.0 | 0.8796 | 0.0256 | 0 | 2024-05-03 | 6.85 - 9.55 | 0.0 | In |
Call | 2024-05-03 CALL at $37.0 | 0.8826 | 0.0301 | 11 | 2024-05-03 | 5.65 - 8.55 | 7.64 | In |
Call | 2024-05-03 CALL at $37.5 | 0.8392 | 0.0331 | 0 | 2024-05-03 | 6.1 - 7.65 | 0.0 | In |
Call | 2024-05-03 CALL at $38.0 | 0.8339 | 0.0364 | 0 | 2024-05-03 | 4.75 - 6.35 | 0.0 | In |
Call | 2024-05-03 CALL at $38.5 | 0.7985 | 0.0382 | 0 | 2024-05-03 | 5.1 - 7.1 | 0.0 | In |
Call | 2024-05-03 CALL at $39.0 | 0.9341 | 0.0378 | 2 | 2024-05-03 | 4.3 - 4.8 | 6.05 | In |
Call | 2024-05-03 CALL at $39.5 | 0.7362 | 0.0398 | 0 | 2024-05-03 | 2.61 - 5.65 | 0.0 | In |
Call | 2024-05-03 CALL at $40.0 | 0.9221 | 0.0523 | 54 | 2024-05-03 | 2.72 - 3.8 | 4.09 | In |
Call | 2024-05-03 CALL at $40.5 | 0.914 | 0.0631 | 1 | 2024-05-03 | 2.82 - 3.9 | 3.3 | In |
Call | 2024-05-03 CALL at $41.0 | 0.8341 | 0.0837 | 0 | 2024-05-03 | 2.01 - 2.97 | 0.0 | In |
Call | 2024-05-03 CALL at $41.5 | 0.8786 | 0.1023 | 0 | 2024-05-03 | 1.76 - 2.88 | 0.0 | In |
Call | 2024-05-03 CALL at $42.0 | 0.7147 | 0.1038 | 17 | 2024-05-03 | 0.86 - 3.75 | 2.15 | In |
Call | 2024-05-03 CALL at $42.5 | 0.8367 | 0.1958 | 0 | 2024-05-03 | 0.94 - 2.19 | 1.31 | In |
Call | 2024-05-03 CALL at $43.0 | 0.8554 | 0.3394 | 3 | 2024-05-03 | 0.69 - 0.94 | 0.75 | In |
Call | 2024-05-03 CALL at $43.5 | 0.6243 | 0.5858 | 26 | 2024-05-03 | 0.35 - 0.39 | 0.34 | In |
Call | 2024-05-03 CALL at $44.0 | 0.32 | 0.5678 | 1059 | 2024-05-03 | 0.11 - 0.13 | 0.13 | Out |
Call | 2024-05-03 CALL at $44.5 | 0.1376 | 0.305 | 349 | 2024-05-03 | 0.03 - 0.05 | 0.05 | Out |
Call | 2024-05-03 CALL at $45.0 | 0.058 | 0.1431 | 1804 | 2024-05-03 | 0.01 - 0.03 | 0.02 | Out |
Call | 2024-05-03 CALL at $45.5 | 0.0284 | 0.0706 | 1073 | 2024-05-03 | 0.01 - 0.02 | 0.01 | Out |
Call | 2024-05-03 CALL at $46.0 | 0.0396 | 0.0674 | 985 | 2024-05-03 | 0.0 - 0.02 | 0.02 | Out |
Call | 2024-05-03 CALL at $46.5 | 0.0207 | 0.0377 | 480 | 2024-05-03 | 0.0 - 0.01 | 0.01 | Out |
Call | 2024-05-03 CALL at $47.0 | 0.0986 | 0.0719 | 338 | 2024-05-03 | 0.0 - 0.01 | 0.11 | Out |
Call | 2024-05-03 CALL at $47.5 | 0.0166 | 0.0244 | 223 | 2024-05-03 | 0.0 - 0.01 | 0.01 | Out |
Call | 2024-05-03 CALL at $48.0 | 0.0152 | 0.0204 | 227 | 2024-05-03 | 0.0 - 0.01 | 0.01 | Out |
Call | 2024-05-03 CALL at $51.0 | 0.0243 | 0.017 | 623 | 2024-05-03 | 0.0 - 0.05 | 0.03 | Out |
Call | 2024-05-03 CALL at $52.0 | 0.0223 | 0.0143 | 433 | 2024-05-03 | 0.0 - 0.05 | 0.03 | Out |
Call | 2024-05-03 CALL at $53.0 | 0.0088 | 0.0068 | 317 | 2024-05-03 | 0.0 - 0.01 | 0.01 | Out |
Put | 2024-05-03 PUT at $39.0 | -0.0126 | 0.0145 | 357 | 2024-05-03 | 0.0 - 0.25 | 0.01 | Out |
Put | 2024-05-03 PUT at $39.5 | -0.0138 | 0.0174 | 1 | 2024-05-03 | 0.0 - 0.01 | 0.01 | Out |
Put | 2024-05-03 PUT at $40.5 | -0.0173 | 0.0269 | 128 | 2024-05-03 | 0.0 - 0.01 | 0.01 | Out |
Put | 2024-05-03 PUT at $41.0 | -0.0198 | 0.0351 | 215 | 2024-05-03 | 0.0 - 0.52 | 0.01 | Out |
Put | 2024-05-03 PUT at $41.5 | -0.0508 | 0.075 | 109 | 2024-05-03 | 0.01 - 0.03 | 0.03 | Out |
Put | 2024-05-03 PUT at $42.0 | -0.0539 | 0.1007 | 163 | 2024-05-03 | 0.01 - 0.04 | 0.03 | Out |
Put | 2024-05-03 PUT at $42.5 | -0.059 | 0.1502 | 180 | 2024-05-03 | 0.01 - 0.02 | 0.02 | Out |
Put | 2024-05-03 PUT at $43.0 | -0.1444 | 0.3391 | 232 | 2024-05-03 | 0.04 - 0.05 | 0.05 | Out |
Put | 2024-05-03 PUT at $43.5 | -0.3707 | 0.6082 | 634 | 2024-05-03 | 0.13 - 0.22 | 0.16 | Out |
Put | 2024-05-03 PUT at $44.0 | -0.6879 | 0.5879 | 841 | 2024-05-03 | 0.38 - 0.46 | 0.48 | In |
Put | 2024-05-03 PUT at $44.5 | -0.8477 | 0.3075 | 897 | 2024-05-03 | 0.75 - 0.87 | 0.86 | In |
Put | 2024-05-03 PUT at $45.0 | -0.6046 | 0.0939 | 843 | 2024-05-03 | 0.47 - 2.39 | 1.18 | In |
Put | 2024-05-03 PUT at $45.5 | -0.8362 | 0.1399 | 105 | 2024-05-03 | 1.61 - 1.95 | 1.73 | In |
Put | 2024-05-03 PUT at $46.0 | -0.8855 | 0.1058 | 289 | 2024-05-03 | 1.39 - 2.4 | 2.12 | In |
Put | 2024-05-03 PUT at $46.5 | -0.778 | 0.0882 | 52 | 2024-05-03 | 2.38 - 4.05 | 2.41 | In |
Put | 2024-05-03 PUT at $47.0 | -0.6702 | 0.0582 | 80 | 2024-05-03 | 3.2 - 4.55 | 3.25 | In |
Put | 2024-05-03 PUT at $47.5 | -0.9141 | 0.0601 | 1 | 2024-05-03 | 2.34 - 3.9 | 3.35 | In |
Put | 2024-05-03 PUT at $48.0 | -0.6768 | 0.0477 | 258 | 2024-05-03 | 3.25 - 5.75 | 4.0 | In |
Put | 2024-05-03 PUT at $48.5 | -0.7049 | 0.0472 | 28 | 2024-05-03 | 3.7 - 6.05 | 4.65 | In |
Put | 2024-05-03 PUT at $49.0 | -0.7241 | 0.0454 | 17 | 2024-05-03 | 4.3 - 6.45 | 5.1 | In |
Put | 2024-05-03 PUT at $49.5 | -0.7324 | 0.0428 | 0 | 2024-05-03 | 5.45 - 6.95 | 5.75 | In |
Put | 2024-05-03 PUT at $50.0 | -0.9999 | 0.0293 | 0 | 2024-05-03 | 5.25 - 7.35 | 5.7 | In |
Put | 2024-05-03 PUT at $51.0 | -0.9784 | 0.0158 | 0 | 2024-05-03 | 6.7 - 7.95 | 6.32 | In |
Put | 2024-05-03 PUT at $52.0 | -0.9459 | 0.0239 | 0 | 2024-05-03 | 7.5 - 8.4 | 7.38 | In |
Put | 2024-05-03 PUT at $53.0 | -0.8485 | 0.0311 | 0 | 2024-05-03 | 7.25 - 9.85 | 4.84 | In |
Put | 2024-05-03 PUT at $54.0 | -0.8146 | 0.0289 | 2 | 2024-05-03 | 9.4 - 11.15 | 9.25 | In |
Put | 2024-05-03 PUT at $55.0 | -0.8814 | 0.0251 | 0 | 2024-05-03 | 11.05 - 12.4 | 5.69 | In |
Put | 2024-05-03 PUT at $56.0 | -0.8629 | 0.0242 | 0 | 2024-05-03 | 12.15 - 13.6 | 6.7 | In |
Put | 2024-05-03 PUT at $57.0 | -0.9589 | 0.0137 | 0 | 2024-05-03 | 11.65 - 13.4 | 7.73 | In |
Put | 2024-05-03 PUT at $58.0 | -0.8825 | 0.0207 | 0 | 2024-05-03 | 13.35 - 14.8 | 0.0 | In |
Put | 2024-05-03 PUT at $59.0 | -0.962 | 0.0117 | 0 | 2024-05-03 | 13.95 - 15.4 | 0.0 | In |
Put | 2024-05-03 PUT at $60.0 | -0.8695 | 0.0191 | 0 | 2024-05-03 | 14.35 - 16.95 | 0.0 | In |
Put | 2024-05-03 PUT at $61.0 | -0.9189 | 0.0155 | 0 | 2024-05-03 | 16.35 - 18.9 | 0.0 | In |
Put | 2024-05-03 PUT at $62.0 | -0.9056 | 0.0158 | 0 | 2024-05-03 | 18.2 - 19.25 | 0.0 | In |
Put | 2024-05-03 PUT at $63.0 | -0.8415 | 0.0175 | 0 | 2024-05-03 | 17.55 - 20.3 | 17.55 | In |
Put | 2024-05-03 PUT at $64.0 | -0.9464 | 0.0112 | 0 | 2024-05-03 | 19.3 - 21.7 | 0.0 | In |
Put | 2024-05-03 PUT at $65.0 | -0.9305 | 0.0123 | 0 | 2024-05-03 | 20.85 - 22.35 | 0.0 | In |
Put | 2024-05-03 PUT at $70.0 | -0.8592 | 0.0137 | 0 | 2024-05-03 | 25.25 - 27.3 | 0.0 | In |
Bristol Myers Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Bristol Myers Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Bristol Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bristol Myers without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Bristol Myers Corporate Directors
Bristol Myers corporate directors refer to members of a Bristol Myers board of directors. The board of directors generally takes responsibility for the Bristol Myers' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bristol Myers' board members must vote for the resolution. The Bristol Myers board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Togo West | Independent Director | Profile | |
| Michael Bonney | Independent Director | Profile | |
| Alan Lacy | Independent Director | Profile | |
| Robert Bertolini | Independent Director | Profile |
Already Invested in Bristol Myers Squibb?
The danger of trading Bristol Myers Squibb is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bristol Myers is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bristol Myers. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bristol Myers Squibb is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.34 | Earnings Share (3.10) | Revenue Per Share 22.212 | Quarterly Revenue Growth 0.047 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.